← SynDRA
BASMISANIL
SynDRA canonical compound SYN0038391 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | GABRA1 | GABRA5 |
| Mechanism of action | GABA receptor inverse agonist |
All known targets
Mechanisms of action (all sources)
- GABRA5 NEGATIVE ALLOSTERIC MODULATOR
- GABA receptor inverse agonist
- GABRA5 MODULATOR
Cross-references
Synonyms
- RG1662
- RG-1662
- RO-5186582
- RO5186582
- RO5186582-000
- UNII-788PET5SUA
- 788PET5SUA
- (1,1-Dioxidothiomorpholino)(6-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl)methoxy)pyridin-3-yl)methanone
- Basmisanil [INN]
- Basmisanil [USAN:INN]
- Basmisani
- Basmisanil(RG1662)
- Basmisanil (USAN/INN)
- SCHEMBL2685527
- CHEMBL3681419
- MolPort-044-561-818
- VCGRFBXVSFAGGA-UHFFFAOYSA-N
- BDBM133427
- EX-A1272
- AKOS032947142
- ZINC145814743
- DB11877
- CS-6046
- HY-16716
- (1,1-Dioxo-4-thiomorpholinyl)(6-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl)methoxy)pyridin-3-yl)metha
- RG 1662
- basmisanilum
- RefChem:561100
- DTXCID101517407
- Basmisanil (RG1662)
- MFCD28902245
- BASMISANIL [USAN]
- Basmisanil(RG1662)?
- BASMISANIL [WHO-DD]
- C21H20FN3O5S
- orb1300014
- GTPL10427
- SB18780
- AC-35398
Look up BASMISANIL in the interactive SynDRA portal →